Anzeige
Meldung des Tages: Die nächsten 10.000 Bohrmeter könnten alles verändern, während andere Explorer noch planen

Invesco Global Clean Energy ETF News

ETF
WKN:  A2JNUA ISIN:  US46138G8472 US-Symbol:  PBD
15,981 €
+0,00 $
0,00%
15,981 € 02.03.26
Depot/Watchlist
Indexbildung
Ertragsverwendung
-
Lfd. Kosten
-
Fondsgröße
-  
Tracking Error
-
Währung
FWW Fundstars
keine Bewertung

Invesco Global Clean Energy ETF News

05.01.26 - PR Newswire
Protalix BioTherapeutics Letter to Stockholders
Protalix BioTherapeutics Letter to Stockholders PR Newswire
13.11.25 - PR Newswire
Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results
Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results PR Newswire
14.08.25 - PR Newswire
Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results
Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results PR Newswire
07.08.25 - PR Newswire
Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025
Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025 PR Newswire
30.06.25 - PR Newswire
Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®
Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes® PR Newswire
14.05.25 - PR Newswire
Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC PR Newswire
05.05.25 - PR Newswire
Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025
Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025 PR Newswire
24.03.25 - PR Newswire
Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025
Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025 PR Newswire
17.03.25 - PR Newswire
Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results
Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results PR Newswire

Newssuche

Videos

newspaper
10.03.26 -10,03%
Technical Trading: DAX Long Chance
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »